Kymera Therapeutics (KYMR) EBT Margin (QoQ) (2019 - 2026)
Kymera Therapeutics (KYMR) EBT Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 197,131.00 |
| Dec 31, 2025 | 898,320.00 |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -101,789.00 |
| Mar 31, 2025 | 20,366.00 |
| Dec 31, 2024 | 482,328.00 |
| Sep 30, 2024 | -549,477.00 |
| Jun 30, 2024 | 141,674.00 |
| Mar 31, 2024 | -145,821.00 |
| Dec 31, 2023 | 354,173.00 |
| Sep 30, 2023 | -291,024.00 |
| Jun 30, 2023 | 17,698.00 |
| Mar 31, 2023 | -94,819.00 |
| Dec 31, 2022 | 74,865.00 |
| Sep 30, 2022 | -24,708.00 |
| Jun 30, 2022 | 100,978.00 |
| Mar 31, 2022 | -152,805.00 |
| Dec 31, 2021 | 110,611.00 |
| Sep 30, 2021 | -13,178.00 |
| Jun 30, 2021 | -24,069.00 |